Cargando…
Antiviral activity of some benzo[g]quinazolines against coxsackievirus B4: biological screening and docking study
BACKGROUND: Serotype coxsackievirus B (CVB) infection has been linked to viral myocarditis, dilated cardiomyopathy, meningitis, and pancreatitis in children and young adults. As of yet, no antiviral drug has been authorized for the treatment of coxsackievirus infection. Therefore, there is perpetual...
Autores principales: | Abuelizz, Hatem A., Bakheit, Ahmed H., Marzouk, Mohamed, El-Senousy, Waled M., Abdellatif, Mohamed M., Mostafa, Gamal A. E., Saquib, Quaiser, Hassan, Sawsan B., Al-Salahi, Rashad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10200032/ https://www.ncbi.nlm.nih.gov/pubmed/37210695 http://dx.doi.org/10.1007/s43440-023-00495-z |
Ejemplares similares
-
Evaluation of Some Benzo[g]Quinazoline Derivatives as Antiviral Agents against Human Rotavirus Wa Strain: Biological Screening and Docking Study
por: Abuelizz, Hatem A., et al.
Publicado: (2023) -
Biological Investigation of 2-Thioxo-benzo[g]quinazolines against Adenovirus Type 7 and Bacteriophage Phi X174: An In Vitro Study
por: Abuelizz, Hatem A., et al.
Publicado: (2023) -
Benzo[g]quinazolines as antifungal against candidiasis: Screening, molecular docking, and QSAR investigations
por: Abuelizz, Hatem A., et al.
Publicado: (2023) -
Molecular docking study and antiviral evaluation of 2-thioxo-benzo[g]quinazolin-4(3H)-one derivatives
por: Al-Salahi, Rashad, et al.
Publicado: (2016) -
Investigation of some benzoquinazoline and quinazoline derivatives as novel inhibitors of HCV-NS3/4A protease: biological, molecular docking and QSAR studies
por: Abuelizz, Hatem A., et al.
Publicado: (2020)